In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Poster Session 4: Chronic Heart Failure – Pathophysiology and Mechanisms
Session

Event : Heart Failure 2019

Topic : Other

  • Session type : Poster Session
  • Date : 28 May 2019
  • Time : 10:30 - 14:30

18 presentations in this session

Exercise unmasks greater arterial stiffness and arterial load in HFpEF patients vs hypertensive controls

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Pathophysiology and Mechanisms
  • Speaker : L Panah (Boston,US)

Impact of the geriatric nutritional risk index in non-diabetic patients aged >80 years with heart failure with preserved ejection fraction

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Pathophysiology and Mechanisms
  • Speaker : Y Mitsuke (Awara,JP)

Red blood cell distribution width predicts 5-years all cause mortality in patients with preserved ejection fraction heart failure

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Pathophysiology and Mechanisms
  • Speaker : R Siliste (Bucharest,RO)

Prognostic value of post-exercise oxygen uptake kinetics in heart failure with preserved ejection fraction

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Pathophysiology and Mechanisms
  • Speaker : I Giverts (Moscow,RU)

Arterial stiffness and the autonomic nervous system function with different phenotypes of heart failure with preserved ejection fraction

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Pathophysiology and Mechanisms
  • Speaker : N Kurlykina (Moscow,RU)

Galectin-3, AGEs serum levels and endothelial function in post infarction heart failure patients with preserved ejection fraction

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Pathophysiology and Mechanisms
  • Speaker : O Sirenko (Dnipropetrovsk,UA)

Dynamics of sST2 and NTproBNP in heart failure with a preserved ejection fraction in acute myocardial infarction

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Pathophysiology and Mechanisms
  • Speaker : V Larina (Moscow,RU)

The impact of a clinical educational and self-care intervention in patients with heart failure with preserved ejection fraction

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Pathophysiology and Mechanisms
  • Speaker : H Bolam (Waterlooville,GB)

The sophisticated echo parameters in diabetic and non-diabetic patients with preserved ejection fraction after STEMI

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Pathophysiology and Mechanisms
  • Speaker : G Krljanac (Belgrade,RS)

Influence of cardioversion on left atrial volume and function in patients with heart failure and preserved ejection fraction and atrial fibrillation

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Pathophysiology and Mechanisms
  • Speaker : M Von Roeder (Leipzig,DE)

Regional differences in characteristics and correlates of coronary microvascular dysfunction in HFpEF

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Pathophysiology and Mechanisms
  • Speaker : C Hage (Stockholm,SE)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are